Knowstox

Fundamentals snapshot

The Clorox Company

CLX · NYQ · Consumer Defensive · Household & Personal Products

Current price

$83.10

52-week range

$83.09 - $128.90

Market cap

$10.05B

One-glance verdict

Undervalued

$92.72 our estimate vs market $83.10

Wall Street consensus: $100.76 (8.7% higher than our fair-value estimate)

Balance sheet

Distressed

6.82x Adequate

Net debt $5.46B. Interest coverage shows how many times profit covers the interest bill.

What this company does

The Clorox Company

The Clorox Company sells many well-known household products you likely have at home, including Clorox bleach, Glad trash bags, Kingsford charcoal, and Burt's Bees lip balm. The company makes its money from the steady, year-round sales of these essential items that people need to buy repeatedly. This provides a relatively predictable business because customers tend to purchase these products no matter how the economy is doing.

Price history

How the share price has moved

Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2024 Q4 $259.00M FY2025 Q1 $182.00M FY2025 Q2 $127.00M FY2025 Q3 $233.00M FY2025 Q4 $219.00M FY2026 Q1 $57.00M FY2026 Q2 $269.00M FY2026 Q3 $-165.00M
Revenue $1.67B
Net income $187.00M
Diluted EPS 1.54
Operating cash flow $-122.00M
Free cash flow $-165.00M
Revenue $1.67B
Net income $157.00M
Diluted EPS 1.29
Operating cash flow $311.00M
Free cash flow $269.00M
Revenue $1.43B
Net income $80.00M
Diluted EPS 0.65
Operating cash flow $93.00M
Free cash flow $57.00M
Revenue $1.99B
Net income $332.00M
Diluted EPS 2.68
Operating cash flow $294.00M
Free cash flow $219.00M
Revenue $1.67B
Net income $186.00M
Diluted EPS 1.50
Operating cash flow $286.00M
Free cash flow $233.00M
Revenue $1.69B
Net income $193.00M
Diluted EPS 1.54
Operating cash flow $180.00M
Free cash flow $127.00M
Revenue $1.76B
Net income $99.00M
Diluted EPS 0.80
Operating cash flow $221.00M
Free cash flow $182.00M
Revenue $1.90B
Net income $216.00M
Diluted EPS 1.74
Operating cash flow $340.00M
Free cash flow $259.00M

Is it cheap or expensive?

Fair value $92.72 vs current price $83.10

Wall Street consensus is the average analyst price target: $100.76 (8.7% higher than our fair-value estimate).

Our most-likely fair value is $92.72 a share — about 11.6% above today's price of $83.10, so the stock currently looks cheap (undervalued).

undervalued

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 2.5% · Discount 7.2% · Terminal 2.5%

$92.72

Bear

Growth 2.5% · Discount 7.2% · Terminal 2.5%

$92.72

Bull

Growth 4.0% · Discount 7.2% · Terminal 2.5%

$105.57

Is it drowning in debt?

Distressed

Net debt $5.5B. Interest coverage 6.8x.

Net debt $5.46B
Interest coverage 6.82x

The Clorox Company's profit covers its interest bill about 6.8 times over. which is weaker than most peers shown here.

Distressed
Worse cushion Baseline Better cushion
CLX BASELINE The Clorox Company

Total debt $5.60B Interest coverage 6.82x This is the baseline the peer rows are being compared against.

Total debt $35.02B Interest coverage 22.52x +230% vs CLX Carries about 3.3x more debt cushion than CLX.

Total debt $6.54B Interest coverage 9.18x +35% vs CLX Carries about 1.3x more debt cushion than CLX.

Total debt $7.86B Interest coverage 15.85x +133% vs CLX Carries about 2.3x more debt cushion than CLX.

Total debt $2.43B Interest coverage 11.32x +66% vs CLX Carries about 1.7x more debt cushion than CLX.

Total debt $36.90B Interest coverage 9.22x +35% vs CLX Carries about 1.4x more debt cushion than CLX.

What you should know

The case for and against CLX

3 Rewards 1 Risk

Rewards

  • Returns 163.8% on equity, ahead of 66% of its peers.
  • Free cash flow was positive in 10/10 years.
  • Trades at 17.3x P/E vs peer median 22.1x (21.9% cheaper).

Risks

  • Net debt grew 110.3% over 3 years.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
17.28x
Forward P/E
13.27x
P/B
111.69x
P/S
1.50x
EV/EBITDA
13.74x
PEG ratio
1.06x

Profitability

How much profit each dollar creates

Gross margin
42.3%
Operating margin
12.9%
Net margin
8.7%
ROE
163.8%
ROA
8.3%

Health

Liquidity and balance-sheet strength

Debt / equity
22.21x
Current ratio
0.66x
Quick ratio
0.34x
Total debt
$5.60B
Total cash
$143.00M

Growth

How the business has been compounding

Revenue TTM
$6.76B
Revenue 5Y CAGR
-0.8%
EPS TTM
4.81
EPS 5Y CAGR
8.8%

Cash flow

How much cash the business throws off

Operating CF TTM
$576.00M
Free CF TTM
$761.00M
FCF margin
11.3%

Dividend

Shareholder payout

Yield
6.0%
Payout ratio
103.1%
Last ex-div date
2026-08-12